Sign in to view content

Risk of Diabetic Retinopathy Progression in Patients During 1 year of Semaglutide Use

Blake A. Cooper, MD MPH

Video
Published 2022

Related

Anti-VEGF Injections and Risk of Traction Retinal Detachments in Eyes With Proliferative Diabetic Retinopathy: Pooled Analysis of 5 DRCR.net Trials
Hani Salehi-Had, MD
Updates from the Field
Early Switch to the Dexamethasone Implant After Sub-Optimal Response to Anti-VEGF Therapy for Diabetic Macular Edema
Shawn Kavoussi, MD
Annual Meeting Talks
2021
Widefield Fluorescein Angiographic-Guided Aflibercept (WFFAGA) Monotherapy for Proliferative Diabetic Retinopathy (PDR)
Dennis M. Marcus, MD
Annual Meeting Talks
2019

Category: Diabetic Retinopathy

Diabetic Retinopathy

See more